<DOC>
	<DOCNO>NCT01623258</DOCNO>
	<brief_summary>The objective trial define rate upstaging colon carcinoma lymph node metastasis sentinel lymph node ( SLN ) mapping . Null hypothesis : There difference rate lymph node metastasis conventional histopathological processing lymph node SLN mapping detail pathologic examination use immunohistochemistry ( IHC ) patient undergo resection colon carcinoma .</brief_summary>
	<brief_title>A Prospective Randomized Study Comparing Sentinel Lymph Node ( SLN ) Evaluation With Standard Pathological Evaluation Staging Colon Carcinoma</brief_title>
	<detailed_description />
	<criteria>1 . 18 year age 2 . Primary , nonmetastatic [ Stage I , II ( localize , node negative ) , III ( localize , node positive ) ] colon carcinoma confirm tissue biopsy colon mass clinically consistent cancer eventually confirm pathology 3 . Palpable mass time surgery 4 . Capable provide informed consent 1 . Prior radiation chemotherapy 2 . Nonpalpable colon tumor 3 . Recurrent Stage IV ( metastatic ) colon cancer 4 . Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>